Egypt vs Landlocked developing countries (LLDCs): Proportion of the target population … measles-containing-vaccine
Egypt
96.0%
in 2024
Landlocked developing countries (LLDCs)
65.0%
in 2024
Egypt rank
28th
Landlocked developing countries (LLDCs) rank
27th
Proportion of the target population … measles-containing-vaccine over time
- Egypt
- Landlocked developing countries (LLDCs)
How they compare
Egypt currently reports 96.0% against 65.0% in Landlocked developing countries (LLDCs), a difference of 31.0%.
That makes Egypt's figure about 1.5 times Landlocked developing countries (LLDCs)'s.
Across all 25 years both countries report, Egypt has been ahead every year.
Egypt ranks 28th and Landlocked developing countries (LLDCs) ranks 27th of 195 countries.
Egypt has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Egypt | Landlocked developing countries (LLDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 96.8% | 11.9% | 84.9% | Egypt |
| 2010s | 94.5% | 26.7% | 67.8% | Egypt |
| 2020s | 95.4% | 56.4% | 39.0% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Egypt or Landlocked developing countries (LLDCs)?
- Egypt, at 96.0% against 65.0% in Landlocked developing countries (LLDCs) as of 2024.
- What is the difference in proportion of the target population who received between Egypt and Landlocked developing countries (LLDCs)?
- 31.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Landlocked developing countries (LLDCs)?
- 25 years are reported by both, from 2000 to 2024.
- How do Egypt and Landlocked developing countries (LLDCs) rank globally for proportion of the target population who received?
- Egypt ranks 28th and Landlocked developing countries (LLDCs) ranks 27th of 195 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.